Trademark: 85179612
Word
ASPEN
Status
Registered
Status Code
800
Status Date
Monday, October 23, 2023
Serial Number
85179612
Registration Number
4342982
Registration Date
Tuesday, May 28, 2013
Mark Type
4000
Filing Date
Thursday, November 18, 2010
Published for Opposition
Tuesday, August 7, 2012

Trademark Owner History
Aspen Pharmacare Holdings Limited - Original Registrant

Classifications
5 Pharmaceutical preparations in the field of human medicine, namely, anti-acid medications, anti-anxiety drugs, antibiotics, antidepressants, antihistamines, drugs, antipsychotics, blood disorder drugs, cancer drugs, decongestants, expectorants, fertility drugs, heart drugs, metabolic drugs to lower cholesterol, control diabetes and thyroid problems, nervous disorder drugs, ophthalmic drugs, and stomach and bowel problem drugs

Trademark Events
Oct 23, 2023
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Oct 23, 2023
Registered And Renewed (First Renewal - 10 Yrs)
Oct 23, 2023
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Oct 23, 2023
Case Assigned To Post Registration Paralegal
Apr 26, 2023
Teas Section 8 & 9 Received
May 28, 2022
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Nov 19, 2019
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Nov 19, 2019
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Nov 14, 2019
Teas Response To Office Action-Post Reg Received
Jun 20, 2019
Post Registration Action Mailed - Sec. 8 & 15
Jun 20, 2019
Case Assigned To Post Registration Paralegal
May 15, 2019
Teas Change Of Correspondence Received
May 15, 2019
Teas Section 8 & 15 Received
May 28, 2018
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Aug 17, 2017
Teas Change Of Correspondence Received
Aug 17, 2017
Teas Change Of Correspondence Received
May 28, 2013
Registered-Principal Register
Apr 23, 2013
Notice Of Acceptance Of Statement Of Use E-Mailed
Apr 20, 2013
Law Office Registration Review Completed
Apr 17, 2013
Allowed Principal Register - Sou Accepted
Apr 10, 2013
Statement Of Use Processing Complete
Mar 19, 2013
Use Amendment Filed
Apr 10, 2013
Case Assigned To Intent To Use Paralegal
Mar 19, 2013
Teas Statement Of Use Received
Oct 2, 2012
Noa E-Mailed - Sou Required From Applicant
Aug 7, 2012
Official Gazette Publication Confirmation E-Mailed
Aug 7, 2012
Published For Opposition
Jul 18, 2012
Notification Of Notice Of Publication E-Mailed
Jul 2, 2012
Law Office Publication Review Completed
Jun 22, 2012
Exparte Appeal Terminated
Jun 22, 2012
Approved For Pub - Principal Register
Jun 20, 2012
Examiner's Amendment Entered
Jun 20, 2012
Notification Of Examiners Amendment E-Mailed
Jun 20, 2012
Examiners Amendment E-Mailed
Jun 20, 2012
Examiners Amendment -Written
Jun 5, 2012
Assigned To Examiner
May 8, 2012
Jurisdiction Restored To Examining Attorney
Apr 12, 2012
Notification Of Action Denying Req For Recon E-Mailed
Apr 12, 2012
Action Denying Req For Recon E-Mailed
Apr 12, 2012
Action Continuing Final - Completed
Mar 19, 2012
Teas/Email Correspondence Entered
Mar 19, 2012
Correspondence Received In Law Office
Mar 13, 2012
Assigned To Lie
Feb 23, 2012
Teas Request For Reconsideration Received
Feb 23, 2012
Ex Parte Appeal-Instituted
Feb 23, 2012
Jurisdiction Restored To Examining Attorney
Feb 23, 2012
Exparte Appeal Received At Ttab
Jan 30, 2012
Teas/Email Correspondence Entered
Jan 30, 2012
Correspondence Received In Law Office
Jan 30, 2012
Teas Request For Reconsideration Received
Aug 23, 2011
Notification Of Subsequent Final Emailed
Aug 23, 2011
Subsequent Final Emailed
Aug 23, 2011
Subsequent Final Refusal Written
Aug 22, 2011
Notification Of Final Refusal Emailed
Aug 22, 2011
Final Refusal E-Mailed
Aug 22, 2011
Final Refusal Written
Jul 29, 2011
Teas/Email Correspondence Entered
Jul 29, 2011
Correspondence Received In Law Office
Jul 29, 2011
Teas Response To Office Action Received
Mar 14, 2011
Notification Of Non-Final Action E-Mailed
Mar 14, 2011
Non-Final Action E-Mailed
Mar 14, 2011
Non-Final Action Written
Feb 28, 2011
Assigned To Examiner
Nov 23, 2010
New Application Office Supplied Data Entered
Nov 22, 2010
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24